Antibiotic Selection for Bacterial Diarrhea
Azithromycin is the preferred first-line empiric antibiotic for bacterial diarrhea requiring treatment, particularly for dysentery (bloody diarrhea with fever) or severe febrile diarrhea, due to widespread fluoroquinolone resistance in Campylobacter and Shigella species. 1, 2
When to Use Antibiotics (and When NOT to)
Indications for empiric antibiotics:
- Dysentery (bloody diarrhea with fever and abdominal pain) presumed due to Shigella 1, 2
- Infants <3 months of age with suspected bacterial etiology 2
- Recent international travelers with fever ≥38.5°C and/or signs of sepsis 2
- Immunocompromised patients with severe illness and bloody diarrhea 2
- Suspected enteric fever with sepsis features 2
Absolute contraindications:
- NEVER use antibiotics for suspected STEC O157 or Shiga toxin 2-producing E. coli infections - this increases risk of hemolytic uremic syndrome 2, 3
- Asymptomatic contacts of patients with diarrhea should not receive antibiotics 2
- Mild, non-bloody, non-febrile watery diarrhea does not require antibiotics 3
First-Line Antibiotic: Azithromycin
Dosing regimens:
Why azithromycin is superior:
- Fluoroquinolone resistance in Campylobacter now exceeds 90% in Southeast Asia, India, and increasingly worldwide 1, 2, 3
- Azithromycin demonstrated superiority over levofloxacin in Thailand, reducing diarrhea duration by >32 hours 1
- Achieves 100% clinical and bacteriological cure rates for Campylobacter 3
- More effective than fluoroquinolones for Shigella infections 1
- Superior to ciprofloxacin for cholera, reducing diarrhea duration by >1 day 1, 2
Pathogen coverage:
- Campylobacter jejuni (first choice) 1
- Shigella species (first choice) 1
- Vibrio cholerae (first choice) 1, 2
- Salmonella species (when treatment indicated) 1
Second-Line Alternative: Fluoroquinolones
Use ciprofloxacin ONLY when:
- Azithromycin is unavailable 3
- Geographic region has documented low fluoroquinolone resistance 1, 3
- Non-dysenteric watery diarrhea in areas without high Campylobacter resistance 1
Dosing:
- Ciprofloxacin 750 mg single dose or 500 mg twice daily for 3 days 1
- Levofloxacin 500 mg daily for 3 days 1
Critical limitations:
- Fluoroquinolone resistance exceeds 90% for Campylobacter in many regions 1, 2
- Inferior outcomes for Shigella compared to azithromycin 1
- FDA warnings for serious adverse effects including tendon rupture, QT prolongation, and C. difficile infection 1, 3
- Should be avoided if ciprofloxacin MIC ≥0.12 μg/mL for Shigella even if reported as "susceptible" 1
Pathogen-Specific Recommendations
For Campylobacter infections:
For Shigella infections:
- Azithromycin or ceftriaxone are first-line 1
- Ciprofloxacin or TMP-SMX only if susceptible 1
- Beta-lactams (ceftriaxone) more effective than fluoroquinolones when 90% Shigella confirmed 1, 2
For non-typhoidal Salmonella:
- Usually NOT indicated for uncomplicated infection 1
- Treat only if: neonates (<3 months), age >50 with atherosclerosis, immunosuppression, cardiac disease, or significant joint disease 1
- If treatment needed: ceftriaxone, ciprofloxacin (if susceptible), TMP-SMX (if susceptible), or amoxicillin (if susceptible) 1
- For bacteremia: ceftriaxone PLUS ciprofloxacin to avoid initial treatment failure 1
For Salmonella typhi (typhoid fever):
For Vibrio cholerae:
- Azithromycin (single dose) superior to ciprofloxacin 1, 2
- Doxycycline alternative 1, 2
- Reduces diarrhea duration by ~1.5 days and stool volume by 50% 1, 2
For Yersinia enterocolitica:
- TMP-SMX (first choice) 1
- Alternatives: fluoroquinolone, cefotaxime, or doxycycline 1
- For severe disease: third-generation cephalosporin plus gentamicin 1
Special Situation: Clostridium difficile Infection
This requires DIFFERENT antibiotics - do not use azithromycin or fluoroquinolones:
- Oral vancomycin 125 mg four times daily for 10 days (first choice) 1, 4
- Fidaxomicin 200 mg twice daily for 10 days (alternative, lower recurrence rates) 1
- Metronidazole 400-500 mg three times daily for 10 days (acceptable for non-severe CDI in children or adults who cannot obtain vancomycin/fidaxomicin) 1
Critical point: Parenteral vancomycin is NOT effective for CDI - must use oral formulation 4
Pediatric Considerations
For children requiring antibiotics:
- Third-generation cephalosporin for infants <3 months or those with neurologic involvement 2
- Azithromycin for other children, based on local susceptibility patterns 2
- Fluoroquinolones should be avoided in pediatric patients due to increased adverse events including joint/surrounding tissue effects 5
What NOT to Use
Avoid these antibiotics due to resistance:
- TMP-SMX (co-trimoxazole): Increasing resistance compromises efficacy 1, 3
- Ampicillin: Widespread resistance 3
- Erythromycin: Widespread bacterial resistance 3
- Tetracyclines (except doxycycline specifically for cholera) 3
Critical Pitfalls to Avoid
Geographic resistance patterns matter:
- Default to azithromycin in Southeast Asia regardless of severity due to >90% fluoroquinolone resistance 1, 2, 3
- Fluoroquinolones may still be reasonable in regions with documented low resistance 1
Drug interactions:
- Avoid aluminum or magnesium-containing antacids with azithromycin - they reduce absorption 3
Monitoring requirements:
- Obtain stool cultures before antibiotics when possible, though empiric therapy warranted in severe cases 3
- Reassess patients not responding within 48-72 hours for complications, resistance, or non-infectious causes 2, 3
Rehydration is paramount:
- Oral rehydration solution (50-90 mEq/L sodium) for mild-moderate dehydration 2, 3
- Intravenous fluids for severe dehydration, shock, altered mental status, or ileus 1, 2
- Antibiotics are adjunctive - rehydration is the cornerstone of all diarrhea management 1, 2, 3
Immunocompromised patients: